Brief: Astrazeneca Pharma India Terminates Distribution Agreement For Dapagliflozin With Abbott Healthcare
28/05/2021 09:39
May 28 (Reuters) - Astrazeneca Pharma India ASTR.NS :
* TERMINATION OF DISTRIBUTION AGREEMENT FOR DAPAGLIFLOZIN
BETWEEN
CO, ABBOTT HEALTHCARE
Source text for Eikon: ID:nBSE1gjy9B
Further company coverage: ASTR.NS ABOT.NS ABT.N
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Astrazeneca Pharma India
See all newsBrief: Astrazeneca Pharma India Receives Permission To Import And Sell Trastuzumab Deruxtecan For Additional Indication
Brief: Astrazeneca Pharma Says Bhavana Agrawal Resigns As CFO
Brief: Astrazeneca Pharma India Receives Permission To Import And Sell Benralizumab For Additional Indication
Brief: Astrazeneca Pharma India Receives Permission To Import Benralizumab (Fasenra) For Additional Indication
Brief: Astrazeneca Pharma Gets Permission To Import For Sale Of Trastuzumab Deruxtecan